ICH Project

The ICH stands for The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a unique forum where drug regulatory authorities and representatives of the pharmaceutical industry Since its establishment in 1990 and its reorganization on October 23, 2015, ICH has steadily evolved to respond to the globalization of drug development, regulation, and distribution, and the number of member organizations continues to grow.
The objectives of ICH are to ensure the timely and continuous availability of new medicines to patients, to avoid unnecessary duplication of human clinical trials, to ensure the efficient development, registration, and manufacture of safe, effective, and high-quality medicines, and to reduce animal testing without adversely affecting the assessment of safety and efficacy. To promote public health by: avoiding unnecessary duplication of clinical trials in humans; promoting the efficient development, registration, and manufacture of safe, effective, and quality medicinal products; and promoting international harmonization of technical requirements to reduce animal testing without adversely affecting safety and efficacy assessments.